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EARLY onset periodontitis (EOP) is a chronic inflam-
matory periodontal disease with a strong genetic link
affecting  individuals  aged  17  to  25.  In  the  familial
studies we tested the hypothesis about the role of Th1
and Th2 cytokines in the pathogenesis of EOP disease.
The study involved 6 individuals with EOP disease and
their 6 siblings with healthy periodontium. Actinoba-
cillus  actinomycetemcomitans  (A.  a.),  a  bacterium
typical  for EOP,  was detected  in all people studied.
Th1 and Th2 cytokine production was measured after
in vitro stimulation.  Peripheral blood mononuclear
cells (PBMC) were isolated and cultivated for 24h and
7 days with PWM, A. a. or Escherichia coli. The levels
of IL–4, IFN-gamma, IgA, IgG and IgM were measured
by ELISA methods. After in vitro stimulation of PBMC,
a  significantly  higher  production  of  IL–4  and  sig-
nificantly  lower  production  of  IFN-gamma  were
found in the group of patients compared with their
healthy  siblings.  The  increased  level  of  IL–4  in
patients  was  in  good  agreement  with  an  increased
level of IgM after stimulation of lymphocytes with E.
coli.  These  results  support  Seymour’s  hypothesis
according to which patients with progressive disease
primarily  activate  Th2  lymphocytes  while  non-sus-
ceptible individuals activate Th1 lymphocytes.
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profile,  Immunoglobulin,  Peripheral  blood  lymphocytes,
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Introduction
Early onset periodontitis (EOP) is a chronic inflamma-
tory periodontal disease affecting individuals aged 17
to 25.1 Pathological changes of the periodontal tissue
are  characterised  by  a  mild  resorption  of  alveolar
bone and the presence of Actinobacillus actinomyce-
temcomitans  (A.  a.) in  the  gingival  crevice  area.
Functional studies have demonstrated polymorphonu-
clear leukocytes (PMN) chemotactic defects in some
70% of subjects with EOP.
Periodontal disease is caused by bacteria in dental
plaque,  and  evidence  is  accumulating  that  specific
periodontal  pathogens  are  associated  with  the  pro-
gressive  form  of  the  disease.1,2 However,  some
individuals harbour these specific bacteria but do not
appear  to  show  evidence  of  disease  progression.
Patient susceptibility is most likely genetically deter-
mined, although a number of local and environmental
factors are thought to influence disease expression.3
Immunological mechanisms have been implicated
in the pathogenesis of periodontal disease for over 30
years. In the 1970s, attention focused on the partici-
pation of peripheral blood T lymphocytes in response
to the action of dental plaque bacteria and on their
role in the development of inflammation.4 Since then
many papers have been published that concern the
relationship between peripheral blood mononuclear
cells  (PBMC)  blastic  transformation  and  periodonti-
tis.5–7 The significance of the dental plaque bacteria
on polyclonal B lymphocyte activation was really only
studied later.7,8 Results showed that both specific and
non-specific mechanisms of B lymphocyte activation
can  play  a  role  in  the  pathogenesis  of  periodontal
disease and that they can be highly influenced by the
treatment.8 –13 At the same time, immunological stud-
ies  clearly  established  the  B  cell/plasma  cell  dom-
inance of the periodontitis lesion.11,12
Both specific and non-specific activation are regu-
lated  by T  lymphocytes.  Based  on  the  concept  of
functional Th1/Th2 and Tc1/Tc2 subsets,14,15 a model
for the pathogenesis of periodontal disease has been
constructed.16,17 According  to  the  hypothesis  of
Seymour  et  al.,16 patients  with  progressive  disease
activate  mainly Th2  lymphocytes  in  response  to  an
antigenic  stimulus  whereas  patients  with  the  slow
type of the disease activate Th1 lymphocytes. In the
latter response it is proposed that a local expansion of
the B cell population would result, on the one hand,
in  the  production  of  IL–1  and  hence  subsequent
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production  of  specific  antibodies.  It  is  further  pro-
posed that if protective antibody is produced it could
result in the elimination of the organism and disease
progression would cease. Production of antibody that
is  non-protective  would,  however,  result  in  con-
tinuous connective tissue breakdown.
Our present study concerns the effect of short-term
cultivation  of  peripheral  blood  lymphocytes  with
pokeweed mitogen (PWM), A. a. and Escherichia coli
on the formation of IL–4 and IFN-gamma in patients
with  early  onset  periodontitis  and  their  healthy
siblings. A. a. has been suggested to play a pathogenic
role  in  the  development  of  this  disease.1 In  our
previous  studies  we  have  shown  that  polyclonal
activation of B cells with a suspension of E. coli leads
to high production of immunoglobulins by PBMC of
patients  with  periodontitis.18 The  results  should
contribute to finding the origins of the susceptibility
to early onset periodontitis.
Materials and methods
Two years before beginning this study the group of 47
patients with EOP was collected from a set of 9225
young  (16–19  years)  individuals  at  the  Institute  of
Dental Research. These patients met the basic clinical
diagnosis criterion of periodontitis: they had at least
one periodontal pocket deeper than 3 mm, situated in
the region of the molars or incisors, inflammation of
gingiva and the presence of the suspect pathogen–
the  bacterium  A.  a.–in  the  sulcular  region. There
were no individuals with systemic disease or pregnant
women in the group of patients.
During the familial study19 we found that among
the total of 47 patients and their 54 siblings only 6
patients had siblings with healthy periodontium and
presence  of  A. a. in  sulcular  region. These  families
were included in this study.
In  agreement  with  Helsinki  conventions  (1964),
informed consent  for blood collection for immuno-
logical  examination  was  obtained  from  all  persons
examined.
Clinical examination
The  examination  of  patients  at  the  beginning  of
therapy included the determination of gingival inflam-
mation using the gingival index (GI),20 ascertaining
the depth of the pockets with the calibrated probe
and  X-ray. This  was  followed  immediately  by  con-
servative treatment. The dental calculus was removed,
unsatisfactory  fillings  or  crowns  were  restored  and
correct tooth brushing technique was demonstrated.
All  patients  were  thoroughly  instructed  in  oral
hygiene  including  teeth  cleaning  and  gingival  mas-
sage. They were also warned that oral hygiene is the
decisive  factor  in  periodontitis  therapy.  The  con-
servative part of the therapy lasted 4 weeks and was
followed  by  a  10-day  tetracycline  treatment.  Two
weeks after the antibiotic therapy the patients were
invited for a control clinical examination, with further
check-ups at 3-and then 6-month intervals.
This  study  reports  on  the  results  of  an  immuno-
logical  examination  2  years  after  the  start  of  the
therapy.
Bacterial suspension and mitogens
A. a. was isolated from a subgingival locality from the
patients of the experimental group. Bacterial culture
was  incubated  for  48 h  in  Brain  Heart  Infusion
(Oxoid) medium and then inactivated for 20 min at
120°C. The bacterial suspension was washed 4 times
with  physiological  saline,  centrifuged  at  600 g and
adjusted to the required concentration (109 cells/ml)
with RPMI 1640 tissue culture medium.
The suspension of heat-killed bacteria of the E. coli
086 strain  was  obtained  from  the  Department  of
Immunology,  Institute  of  Microbiology, Academy  of
Sciences of the Czech Republic, and diluted to the
experimentally optimal concentration (109 cells/ml)
with RPMI medium.
PWM (Phytolacca americana mitogen, Sigma) and
ConA  (Concanavalin A,  Sigma)  were  diluted  to  the
experimentally optimal concentration (PWM 2 m g/ml,
PWM  2 m g/ml+ConA  10 m g/ml)  with  RPMI  1640
tissue culture medium.
Stimulation of lymphocytes to cytokine and
immunoglobulin production
Mononuclear cells isolated from the peripheral blood
of  the  patients  and  their  siblings  with  healthy
periodontium  were  washed,  diluted  with  a  supple-
mented  tissue  culture  medium  RPMI  1640  to  a
concentration  of  106/ml,  and  cultivated  with  mito-
gens and heat-killed bacteria (A. a. 108/ml and E. coli
108/ml),  as  described  earlier.21 Supernatants  were
taken after 24 h and after 7 days, which were then
stored at –20°C until further assay.
Assay of cytokines and immunoglobulins in
culture media
Cytokine assay.
Cytokines IL–4 and IFN-gamma were assayed in the
tissue culture supernatants using commercial Immu-
notech  France  kits. The  technique  is  based  on  the
sandwich method in  which monoclonal antibody  is
used as a binding antibody, and another biotinylated
monoclonal  antibody  is  used  for  detection.  This
second antibody reacts with  the streptavidin-perox-
idase  conjugate. The  binding  enzymatic  activity  is
determined by adding a chromogen (without TMB),
and  the  colour  intensity  is  measured  on  an  SLT
Spectra II microreader.
J. B´ artov´ a et al.
116 Mediators of Inflammation · Vol 9 · 2000Enzyme linked immunosorbent assay of
immunoglobulins ELISA assay of
immunoglobulins.
Polyclonal antibodies Q-SwaHu-IgM, Q-SwaHu-IgG or
Q-SwaHu-IgA  (Sevac,  Prague)  were  used  as  the
binding  antibodies. After  incubation  and  washings,
control sera with defined immunoglobulin contents
and the supernatants were applied. Following incuba-
tion  and  washing,  peroxidase-labelled  antibodies
against  human  immunoglobulin  (Q-SwaHu-IgM,
Q-SwaHu-IgG  or  Q-SwaHu-IgA)  were  added.  A  1-h
incubation  at  room  temperature  was  followed  by
washing the plates and the redox reaction with OPD
in phosphate ELISA buffer (pH = 6.2) was developed
using hydrogen peroxide. The reaction was stopped
with 1M sulphuric acid and read on an SLT Spectra II
ELISA  reader.  Individual  samples  were  evaluated  in
ng/ml using the KIME E program.
Statistical evaluation
Student’s pair  t-test at  a probability  level of P=0.05
was used to evaluate the significance of differences
between  patients and their  siblings. The results are
presented as mean ± SE.
Results
Cytokine production by PBMC after a 24-h stimulation
by  mitogen  and  bacteria  suspensions  is  shown  in
Table 1. The IFN-gamma formation was found to be
significantly  higher  in  healthy  siblings  than  in  the
patients after stimulation by A. a. and E. coli. On the
other hand, a significantly higher formation of IL–4
was detected in patients after stimulation by A. a. and
E. coli as compared with their healthy siblings.
The  release  of  immunoglobulins  after  a  7-day
stimulation of PBMC by mitogen and bacteria suspen-
sions is shown in Table 2. Compared to their siblings,
patients exhibited a significantly higher IgM level after
polyclonal stimulation with E. coli. The formation of
IgA  was significantly  higher in  the patients  than  in
their siblings in cultures stimulated by both PWM and
ConA.  No  significant  differences  were  found  after
stimulation  of  PBMC  by  other  mitogens  and  in
unstimulated cultures. No significant differences were
found in the level of IgG.
Discussion
Evidence  based  on  microbiological,  immunological
and  animal  studies  has  shown  that  some  forms  of
periodontal disease in adults can remain stable over
many years and not endanger the life of the dentition,
whereas  other  forms,  despite  extensive  treatment,
continue to break down, leading ultimately to tooth
loss.22
The regulatory activity  of T lymphocytes and the
identification  of  which  cytokines  are  present  have
been studied intensively in order to shed some light
on  the  pathogenesis  of  periodontal  disease.  It  has
been shown that individuals susceptible to periodon-
tal disease predominantly activate Th2 lymphocytes,
while  non-susceptible  individuals  activate  Th1
lymphocytes.16
The  verification  of  this  hypothesis  required  a
correct selection of patients. Patients with early onset
periodontitis  (susceptible  individuals)  and  their  sib-
lings  with  healthy  periodontium  (non-susceptible
individuals), both exhibiting presence of A. a., seem
to be ideal for the study of the role of Th1 and Th2
lymphocytes  in  the  pathogenesis  of  the  disease.
Despite the similar genetic backgrounds, similar age
and  similar  hygiene  habits  in  families,  we  found
different  production  of  cytokines  after  in  vitro
stimulation.
The  majority  of  immune  responses  occur  locally
rather than systemically within a small area of tissue:
therefore most authors  have  concentrated on the T
cells isolated from inflamed tissues of patients.16,23 –26
This tissue can be obtained during surgical treatment
of  seriously  affected  patients.  Lymphocytes  isolated
from peripheral blood of patients are rarely used.27–29
The  use  of  PBMC  is  favourable  for  analysing  the
transformation  of  the  immune  response  during  the
disease’s remission, when it is not possible to use cells
from the tissue.
PBMC were capable of expressing mRNA for IL–2,
IL–4,  IL–5,  IL–6,  IL–10,  IL–13  and  IFN-gamma
Cytokine profile in early onset periodontitis
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Table 1.+Release of IFN-gamma and IL–4 after the stimulation (24h) of PBMC by mitogens and antigens
a
Mitogens and activators IFN-gamma (U/ml ´ 1000)
Patients Siblings Significance
IL–4 (ng/ml)
Patients Siblings Significance
PWM 30 ± 12 28 ± 12 92 ± 40 136 ± 65
PWM+ConA 34 ± 11 861 ± 824 175 ± 62 104 ± 45
A. a. 6 ± 2 178 ± 14 P<0.05 394 ± 216 55 ± 22 P<0.05
E. coli 4 ± 1 125 ± 10 P<0.05 149 ± 51 35 ± 19 P<0.05
Unstimulated 740 ± 734 54 ± 4 50 ± 26 52 ± 22
a Student9 s pair t-test at a probability level of P=0.05 was used to evaluate the significance of differences between patients
and their siblings. The results are presented as mean ± SE.J. B´ artov´ a et al.
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.following  stimulation  by  ConA  for  2 h.29 Cells  iso-
lated from affected tissue only expressed IL–10, IL–
6, IL–13 and IFN-gamma. It seems that PBMC were
capable  of  producing  a  whole  spectrum  of  cyto-
kines,  but  after  homing  of  T  cells  into  inflamed
tissue, they were only capable of expressing  either
Th1 or Th2 cytokines.
By  immunohistochemical  analysis  a  higher  per-
centage of IL–4 and IL–6 producing cells was found
in the tissues affected by inflammation.23 Following
in  vitro stimulation  by  Porphyromonas  gingivalis
and  Fusobacterium  nucleatum,  most  lymphocytes
obtained  from  biopsies  of  periodontitis  affected
tissues were of the Th2 phenotype, i.e. they formed
high amounts of Il–4 and only small amounts of IL–2
and IFN-gamma.16 Manhart et al.24 proved that altered
IL–2/IL–4  activities  were  founded  in  lesion  of
patients with early onset periodontitis.
After activation by PHA, CD8+CD28+ cells isolated
from inflamed lesions of patients with adult period-
ontitis 25,26 produced high amounts of IFN-gamma and
were  shown  to  have  cytotoxic  activity,  whereas
CD8+CD28-cells  produced  predominantly  IL–4  and
IL–5 and they showed a suppressive effect.
We found a significantly higher formation of IL–4
and significantly lower formation of IFN-gamma after
E. coli stimulation in patients with EOP as compared
with  their  siblings.  These  results  corroborate  the
finding of a significantly higher count of PBMC that
produce IL–4 after P. gingivalis and Lipopolysacchar-
ide (LPS) stimulation, which was detected by Aoyagi
et al.30 in patients with adult periodontitis.
As  a  B  cell  growth  factor,  IL–4  stimulates  the
proliferation and differentiation of B lymphocytes and
induces the expression of MHCII class II antigens on B
lymphocytes.  It  also  stimulates  the  antigen-specific
antibody response, which has a protective character
and will probably be activated in patients in the resting
stage.16,31 On  the other  hand, polyclonal activation
probably leads to the progression of the disease.
A  higher  production  of  imunoglobulins  after  the
polyclonal stimulation of B lymphocytes was found in
patients compared with their siblings. Compared to
their siblings, patients exhibited a significantly higher
IgM level after polyclonal stimulation with E. coli. The
formation  of  IgA  was  significantly  higher  in  the
patients than in their siblings in cultures co-stimulated
by PWM and ConA.
Prediction of clinical disease activity in patients is
not yet possible, and only the measurement of past
activity is currently available. The establishment of a
means for classifying patients as susceptible or non-
susceptible  is  therefore  necessary  to  define  patient
selection  more  precisely.31 The  pathogenic  mecha-
nisms involved in the development of EOP have yet to
be elucidated, but the prevalent production of IL–4
by  the  patients’  peripheral  blood  lymphocytes  sug-
gests that Th2 cells, and probably B cells, and their
products may play an important role in the pathogen-
esis of this disease.
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